Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT ID: NCT01743612
Last Updated: 2016-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
101 participants
INTERVENTIONAL
2012-01-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
NCT05171114
Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
NCT06291142
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators proposed, in this study, to compare this imaging at basal and after post-occlusive hyperaemia of dorsal and palmar face of hand in 3 groups: healthy subjects, primary Raynaud's phenomenon and systemic sclerosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sclerodermic patients
patients with systemic sclerosis according to Leroy's classification
laser speckle contrast imaging
blood flow recording during 30 minutes after 2 post-occlusive hyperaemia of 5 minutes separated by 30 minutes.
Cooling
blood flow of the hand recording during 30 minutes in a cooling-box
Primary Raynaud's phenomenon
without secondary disease
laser speckle contrast imaging
blood flow recording during 30 minutes after 2 post-occlusive hyperaemia of 5 minutes separated by 30 minutes.
Cooling
blood flow of the hand recording during 30 minutes in a cooling-box
Healthy subjects
18 years old or more
laser speckle contrast imaging
blood flow recording during 30 minutes after 2 post-occlusive hyperaemia of 5 minutes separated by 30 minutes.
Cooling
blood flow of the hand recording during 30 minutes in a cooling-box
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laser speckle contrast imaging
blood flow recording during 30 minutes after 2 post-occlusive hyperaemia of 5 minutes separated by 30 minutes.
Cooling
blood flow of the hand recording during 30 minutes in a cooling-box
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Man ou woman 18 years old or more.
* Without Raynaud's phenomenon or systemic sclerosis.
Raynaud's phenomenon subjects:
* Man ou woman 18 years old or more.
* with primary Raynaud's phenomenon.
Systemic sclerosis:
* Man ou woman 18 years old or more.
* systemic sclerosis in accordance to Leroy's classification.
Exclusion Criteria
* Bosentan, iloprost ou sildenafil treatment
* History of axillary dissection , trauma or surgery
* history of thromboembolic disease or thrombophilia
* minor or law-protected major
* exclusion period in another study
* No affiliation to medicare
* pregnant, parturient or breasting woman
* concomitant serious disease: progressive cancer, liver failure, history of myocardial infarction less than 5 years, angor
* smoking in the 6 last months
* person deprived of liberty by a legal or administrative decision, person under legal protection
* maximal annual indemnification reached.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Luc CRACOWSKI, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CIC, CHU Grenoble
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Center
Grenoble, , France
Vascular Medical Unit
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gaillard-Bigot F, Roustit M, Blaise S, Gabin M, Cracowski C, Seinturier C, Imbert B, Carpentier P, Cracowski JL. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis. Microvasc Res. 2014 Jul;94:90-5. doi: 10.1016/j.mvr.2014.05.007. Epub 2014 Jun 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCIC 11 25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.